Cargando…
Prognostic and Predictive Biomarkers: Tools in Personalized Oncology
Oncology indispensably leads us to personalized medicine, which allows an individual approach to be taken with each patient. Personalized oncology is based on pharmacogenomics and the effect of genetic differences in individuals (germline and somatic) on the way cancer patients respond to chemothera...
Autores principales: | Nalejska, Ewelina, Mączyńska, Ewa, Lewandowska, Marzena Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031398/ https://www.ncbi.nlm.nih.gov/pubmed/24385403 http://dx.doi.org/10.1007/s40291-013-0077-9 |
Ejemplares similares
-
Prognostic and Predictive Epigenetic Biomarkers in Oncology
por: Kamińska, Katarzyna, et al.
Publicado: (2018) -
Prognostic and Predictive Biomarkers in Gliomas
por: Śledzińska, Paulina, et al.
Publicado: (2021) -
Detection of somatic mutations in ctDNA derived from adenocarcinoma patients – EGFR tyrosine kinase inhibitor monitoring preliminary study
por: Lewandowska, Marzena Anna, et al.
Publicado: (2019) -
White Adipocyte Plasticity in Physiology and Disease
por: Bielczyk-Maczynska, Ewa
Publicado: (2019) -
Radio-lncRNAs: Biological Function and Potential Use as Biomarkers for Personalized Oncology
por: Kozłowska-Masłoń, Joanna, et al.
Publicado: (2022)